Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cellular plasma membrane and extracellular matrix (ECM) components represent the fundamental structural boundaries and microenvironmental framework of biological tissues. The plasma membrane is a dynamic phospholipid bilayer that houses essential proteins, including receptors, ion channels, and transporters, which are critical for maintaining cellular homeostasis and mediating response to external stimuli (Alberts et al., 2014). The ECM is an intricate network of macromolecules, such as collagen, proteoglycans, and glycoproteins, that provides physical scaffolding for cells and regulates diverse processes like adhesion, migration, and differentiation (Frantz et al., 2010). Together, these components play vital roles in tissue architecture and intercellular communication. Dysregulation of these components is a hallmark of diseases such as cancer metastasis and organ fibrosis, where the ECM undergoes significant remodeling to promote tumor progression (Yue, 2014). While numerous therapeutic agents target specific molecular entities within these structures, the category itself is too broad and heterogeneous to be defined as a single therapeutic target. Consequently, drug development typically focuses on discrete proteins or enzymes that operate within these compartments rather than the compartments themselves (Bonnans et al., 2014).
Drugs associated with these components typically function by binding to cell-surface receptors to modulate signaling pathways, inhibiting adhesion molecules to prevent cell migration, or enzymatically modifying ECM proteins to alter tissue permeability and structure.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular plasma membrane and extracellular matrix components.